Biovie (BIVI) Invested Capital (2016 - 2020)

Biovie (BIVI) posted Invested Capital of $444451.0 for Q1 2020, up 1381.5% sequentially from $30000.0 in Q4 2019.

Biovie (BIVI) Invested Capital (2016 - 2020) Analysis & Trends

Biovie has reported Invested Capital for 5 years, with the latest figure at $444451.0 in Q1 2020.

Quarterly Invested Capital changed N/A year-over-year to $444451.0 in Q1 2020, while the trailing twelve-month figure through Dec 2020 was $444451.0 (up 1381.5% YoY) and the FY2018 annual result came in at $250000.0, up 614.29% from the prior year.
Invested Capital rose to $444451.0 in Q1 2020 per BIVI's latest filing, from $30000.0 in the prior quarter.
Over five years, Invested Capital peaked at $444451.0 in Q1 2020 and troughed at $8000.0 in Q3 2016.
A 5-year average of $91383.4 and a median of $25000.0 in 2018 frame the typical range for Invested Capital.
The widest YoY moves for Invested Capital: up 614.29% in 2018, down 150.0% in 2018.
Over 5 years, Invested Capital stood at $10000.0 in 2016, then jumped by 250.0% to $35000.0 in 2017, then jumped by 614.29% to $250000.0 in 2018, then tumbled by 88.0% to $30000.0 in 2019, then soared by 1381.5% to $444451.0 in 2020.
According to Business Quant data, Invested Capital over the past three periods registered $444451.0, $30000.0, and $250000.0 for Q1 2020, Q4 2019, and Q2 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	190.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.45 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	380.00 Mn
10	Biovie	14.17 Mn	14.17 Mn	-	-

Download Data